Figure 1.

Summary of clinical consensus for ICI treatment in elderly patients with advanced NSCLC.

The figure represents the main factors involved in the evaluation of elderly patients and expert consensus indications for the choice of first-line treatment with ICI-based regimens in the clinical setting.

CGA, comprehensive geriatric assessment; ICI, immune checkpoint inhibitor; NSCLC, non-small-cell lung cancer; PD-1, programmed cell death protein 1; PD-L1, programmed cell death-ligand 1.

^aAbsolute value of age boundaries to be considered within a multifactorial approach.